B3ENS Co., Ltd.—A Promising Small Giant from the Busan–Ulsan–Gyeongnam Region—Enters Indian Market Jae-Hyun Kim (far right), CEO of B3ENS Co., Ltd., a leading manufacturer of medical hyperbaric oxygen chambers, poses for a commemorative photo after signing a memorandum of understanding (MOU) with India’s state-run enterprises to establish a local joint venture. Photo courtesy of B3ENS Co., Ltd. B3ENS Co., Ltd., a South Korean company specializing in manufacturing medical hyperbaric oxygen therapy (HBOT) chambers, headquartered in Yangsan, Gyeongsangnam-do, has officially entered the vast Indian medical device market. On March 28 in Visakhapatnam, Andhra Pradesh, B3ENS Co., Ltd.’s CEO Jae‑Hyun Kim (first on the right) signed a memorandum of understanding (MOU) with O2 Joy Innovation Pvt Ltd (CEO Tarandeep Kaur Rekhi) and the Indian government-led company Andhra Pradesh MedTech Zone (AMTZ), led by Dr. Jitendra Sharma, to establish a joint venture. This strategic partnership combines South Korea’s advanced medical technology with India’s burgeoning market, marking a milestone toward localized production and sales of HBOT chambers in India. AMTZ is Asia’s largest state-backed advanced medical device manufacturing hub, founded to promote domestic production and global competitiveness in healthcare equipment.B3ENS Co., Ltd. will manufacture HBOT chambers locally at AMTZ facilities, supplying not only the Indian domestic market but also exporting to global markets — enhancing the global reputation of Korean medical devices. B3ENS Co., Ltd. will manufacture HBOT chambers locally at AMTZ facilities, supplying not only the Indian domestic market but also exporting to global markets — enhancing the global reputation of Korean medical devices. As a leading domestic expert, B3ENS Co., Ltd. manages the entire process—from R&D and design to manufacturing and installation—based on precision engineering and field expertise. Their homegrown innovations include explosion-proof designs, flat and curved sliding doors, and versatile solutions across industries. The company holds numerous certifications (GMP, ISO 9001, venture business status, and veterinary medical device manufacturing license), along with three patents and four design patents. Leveraging its technology, the company provides HBOT chambers across healthcare, sports, aesthetics, industrial, and pet-care sectors worldwide. Early on, they developed a sliding-door, seated-type, single-person 3-atmosphere chamber—offering patients safer and more comfortable treatment compared to traditional reclining chambers. This MOU is being recognized as a model of tech cooperation between Korea and India. On March 28, in Visakhapatnam, Andhra Pradesh, key stakeholders from B3ENS Co., Ltd. and India’s state-run AMTZ gathered for a signing ceremony to establish a joint venture. The participants commemorated the event with an official photo. Photo courtesy of B3ENS Co., Ltd. Beyond business, it highlights how Korean medical firms can gain traction in India’s massive market, reinforcing Korea’s global medical device standing. Co-CEOs Jae‑Hyun Kim and Seung‑Won Lee emphasized, “This MOU will be a vital stepping stone for Korean companies in India’s healthcare market. Collaborating with AMTZ, we will advance the global competitiveness of HBOT chambers and deliver innovative treatment solutions to more patients.”The joint venture represents a new paradigm in Korea–India industrial ties—setting a benchmark for future collaboration and boosting both nations’ competitiveness in the global medical device arena. https://www.fnnews.com/news/202504081256347856
